Ubs Asset Management Americas Inc Ardelyx, Inc. Transaction History

Ubs Asset Management Americas Inc

$446 Billion
Q3 2025

A detailed history of Ubs Asset Management Americas Inc transactions in Ardelyx, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 370,109 shares of ARDX stock, worth $2.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

370,109

Previous 634,245 41.65%

Holding current value

$2.17 Million

Previous $2.49 Million 17.82%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$3.92 - $6.64 $1.04 Million - $1.75 Million	-264,136 Reduced 41.65%	370,109 $2.04 Million
Q2 2025 Aug 14, 2025	BUY	$3.28 - $5.51 $365,378 - $613,791	111,396 Added 21.31%	634,245 $2.49 Million
Q1 2025 May 19, 2025	SELL	$4.91 - $6.36 $272,048 - $352,388	-55,407 Reduced 9.58%	522,849 $2.57 Million
Q4 2024 Feb 14, 2025	BUY	$4.49 - $6.85 $638,900 - $974,713	142,294 Added 32.64%	578,256 $2.99 Million
Q3 2024 Nov 14, 2024	SELL	$5.28 - $7.57 $229,384 - $328,871	-43,444 Reduced 9.06%	435,962 $3 Million

Q2 2024 Aug 13, 2024	BUY	$5.89 - $9.31 $1 Million - $1.59 Million	170,309 Added 55.1%	479,406 $3.55 Million
Q1 2024 May 15, 2024	SELL	$6.05 - $9.74 $9,371 - $15,087	-1,549 Reduced 0.5%	309,097 $2.26 Million
Q4 2023 Feb 14, 2024	SELL	$3.29 - $6.64 $6,491 - $13,100	-1,973 Reduced 0.63%	310,646 $1.93 Million
Q3 2023 Nov 13, 2023	BUY	$3.3 - $4.83 $442,695 - $647,944	134,150 Added 75.17%	312,619 $1.28 Million
Q1 2023 May 15, 2023	BUY	$2.68 - $4.79 $478,296 - $854,866	178,469 New	178,469 $854,000
Q2 2021 Aug 16, 2021	BUY	$6.55 - $8.98 $77,145 - $105,766	11,778 Added 15.75%	86,578 $656,000
Q1 2021 May 14, 2021	BUY	$6.1 - $7.69 $84,180 - $106,122	13,800 Added 22.62%	74,800 $495,000
Q4 2020 Mar 01, 2021	BUY	$5.05 - $7.1 $54,035 - $75,970	10,700 Added 21.27%	61,000 $394,000
Q3 2020 Nov 13, 2020	SELL	$5.25 - $7.08 $9,796 - $13,211	-1,866 Reduced 3.58%	50,300 $264,000
Q2 2020 Aug 14, 2020	BUY	$5.37 - $8.11 $280,131 - $423,066	52,166 New	52,166 $360,000

Others Institutions Holding ARDX

# of Institutions

245

Shares Held

161M

Call Options Held

697K

Put Options Held

1.61M

View Full List

About ARDELYX, INC.

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $908M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

More about ARDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Ardelyx, Inc. Transaction History